News

Press Release

Go to Topics

Back number

2018

Sysmex Launches Flow FISH Testing System for Research Applications That Utilizes Imaging FCM Technology to Automate FISH Testing
Sysmex Receives Manufacturing and Marketing Approval to Use the OncoGuide™ NCC Oncopanel System in Cancer Genome Profiling
Sysmex Launches New Products in the Hemostasis Field: Automated Blood Coagulation Analyzers CN-6000 and CN-3000
-Making Testing Even More Efficient and of Higher Quality through Higher Levels of Productivity, Reliability, and Operability-
With a View to New Value Creation, Sysmex Launches a Research Assay Service for HDL Function Measurement
-Aiming to Prevent Atherosclerosis-Related Diseases and Provide Treatment Opportunities-
Sysmex Wins the Encouragement Prize for the First Time in the 6th WICI Japan Award for Excellence in Integrated Reporting
Sysmex Launches Revohem FIX Chromogenic, a Blood Coagulation Factor IX Measurement Kit
-Japan’s First Coagulation Factor IX Measurement Kit Using Chromogenic Assay, Helping to Diagnose and Assist in the Treatment of Hemophilia B-
Sysmex and MolecularMD Commence Global Partnership to Address the Challenges in Companion Diagnostics Development and Commercialization
-To Accelerate Precision Medicine Through Globally Proven Experience-
Sysmex Launches Single Molecule Fluorescence Microscope HM-1000 for Research Use
-Supporting R&D Related to New Therapeutic Drugs and Diagnostic Methods with a Super-Resolution Fluorescence Microscope Having High Spatial Resolution-
Sysmex Wins Awards in 2018 Kinki Local Commendations for Innovations
Summary of Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2019 (PDF:579KB)
Announcement Regarding Differences between Actual and Forecast Figures for the Six Months Ended September 30, 2018, and Revision of Full-Year Financial Forecasts (PDF:62KB)
Strengthening Our Global R&D Structure to Foster Early-Stage Innovation
RIKEN GENESIS to Perform Sequencing Analysis for Todai OncoPanel
-Supporting Launch of Advanced Medical Care “Cancer Gene Panel Testing” by the University of Tokyo-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Third Consecutive Year
Announcement of Personnel Change (PDF:52KB)
Sysmex Launches New Product for the China Market in Its Automated Hematology Analyzer XS-Series
-Using a New Product Supply Scheme to Accelerate Business Expansion in China-
Sysmex, Toppan Printing, and RIKEN GENESIS Commence Launch of Fully Automated System (Research Use Only) to Detect Gene Mutations in Cancer Tissue
-Streamlining the Gene Testing Processes to Standardize the Testing-
Sysmex Partec’s CyFlow™ Counter System, a System to Test for CD4+ Lymphocytes, Receives WHO Prequalification
-Aiming to Help Improve the Quality of HIV Diagnosis and Treatment in Emerging Markets and Developing Countries-
Sysmex America Opens “Center for Learning,” Expanding Training Facilities for Customers in North America
-Enhancing Its Service and Support to Further Increase Customer Satisfaction-
Sysmex to Launch HISCL™ Presepsin Assay Kit for Sepsis Testing
-Contributes to early diagnosis of bacterial sepsis by promoting presepsin testing in conjunction with the HISCL™-Series-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2019 (PDF:626KB)
Sysmex and JVCKENWOOD Jointly Establish Company to Use Micro and Nano-Fabrication Technology to Develop and Manufacture IVD Biodevices
Sysmex Establishes Subsidiary in Egypt and Begins Conducting Direct Sales and Services
Our Views and Policy regarding Investment Unit Reduction (PDF:31KB)
Sysmex, the Foundation for Biomedical Research and Innovation at Kobe, and Kyoto University Begin Joint Research on Technologies for Diagnosing Immunological Diseases
Sysmex Launches New Products in Its System for the Testing of Cancer Lymph Node Metastasis Using the OSNA™ Method: Gene Amplification Detector RD-200 and LYNOAMP™ CK19
-Contributing to Standardization in the Testing of Cancer Lymph Node Metastasis by Shortening Testing Times and Augmenting Processing Capacity-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 (PDF:415KB)
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend (Commemorative Dividend) for the Fiscal Year Ended March 31, 2018 (PDF:87KB)
Notice of the Booking of a Provision of Allowance for Doubtful Accounts (Non-Consolidated) Related to Loans to an Affiliated Company (PDF:40KB)
Sysmex Group Formulates New Long-Term Management Goals
Celebrating Our 50th Anniversary by Taking on New Challenges to Move to the Next Stage
Sysmex Announces “Sysmex Eco-Vision 2025”
—To contribute to a sustainable society—
Sysmex to Establish Bio-Diagnostic Reagent Center
Reinforcing Our Diagnostic Reagent Development and Production Function by Establishing a Location to Handle Integrated Development through Production and Distribution of Bio-Diagnostic Reagents
Sysmex Employee to Receive the “Medal with Purple Ribbon,” a Spring 2018 Medal of Honor
Sysmex to Launch JICA Project in the Republic of Ghana:
"Collaboration Program for Disseminating Automated Urinalysis Diagnosis Technology”
Sysmex Obtains Certification under ISO Guide 34, the International Standard for the Competence of Reference Material Producers
-Initiatives toward Further Standardization and Quality Improvement of Clinical Testing-
Sysmex Launches Caresphere,™ a New Network Solution
-Supporting the Intelligent Use of Information for the Healthcare of the Future, Where the Use of Information is Accelerating-
Sysmex and ImmuniT Research Enter Agreement on the Sublicensing of a Patent Related to a Diagnosing Method for Predicting Efficacy of Immune Checkpoint Inhibitors
Advanced Medical Care Approval Received for Multiplex Gene Panel Testing to Advance Personalized Medicine
Sysmex Formulates New Corporate Message:“Lighting the way with diagnostics”
Sysmex to Launch the Automated High-sensitive Immunoassay System for Research Applications HI-1000
-Promoting R&D on New Biomarkers Aimed at Achieving Personalized Medicine through Liquid Biopsy-
Japan’s first-ever industry-academia alliance to realize the development of innovative medicine in Japan
Implementation of a one-stop bioresource project in Kyoto University, and the establishment of KBBM Co., Ltd. as a model of “industry-in-the-academia” industry-academia partnership
Sysmex to Be Special Sponsor of the Kobe Marathon 2018
-We are pleased to have sponsored this exciting event since its inception in 2011-
Announcement of Organizational and Personnel Changes (PDF:182KB)
Sysmex Celebrates Its 50th Anniversary of Establishment
-Gratitude for All the Support over the Past 50 Years and a Commitment to Continue Taking on Challenges toward the Advancement of Healthcare-
FY2017 Nakatani Award and Research Grant Recipients Announced (PDF:117KB)
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2018 (PDF:347KB)
Sysmex Harmony Co., Ltd., Certified as Special Subsidiary Company